Acadia Pharmaceuticals buy StockNews.com
Start price
03.08.24
/
50%
€17.09
Target price
03.08.25
-
Performance (%)
18.53%
End price
04.08.25
€20.25
Summary
This prediction ended on 04.08.25 with a price of €20.25. The prediction had a final performance of 18.53%. StockNews_com has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 4.679% | 4.679% | 39.365% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by StockNews_com for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Acadia Pharmaceuticals
Stopped prediction by StockNews_com for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.60
14.09.24
14.09.24
-
14.09.25
14.09.25
36.96%
15.09.25
15.09.25
